Fundraising Fox
Pattern Bioscience
Austin, US · Founded 2016 · 76 employees on LinkedIn · 5 known investors
Find your way into Pattern Bioscience
Sign up to see every warm intro you have to Pattern Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pattern Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
Founders & leadership
Pattern Bioscience was founded in 2016 by Nick Arab and Ross Johnson.
Board
Investors · 5
How we know: AMR Action Fund's portfolio page · the company's own site · funding news · pattern.bio · Not right? Tell us
How we know: Illumina Ventures's portfolio page · the company's own site · a partner's Signal profile · funding news · pattern.bio · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$83.7M disclosed across 5 of 6 rounds · 2018–2025
- Undisclosed amountSeries AAug 2020Source ↗
▶$44.2MraisedAug 2025 · 6 investors · BiotechnologyRule 506(b)
- Junjun GaoDirector
- Scott MendelDirector
- Greg WoodDirector
- Nicholas NaclerioDirector
- Patrick BalthropDirector
- Nicolas ArabExecutive Officer, Director
- Carey-Ann BurnhamExecutive Officer, Director
- Offering amount
- $61.2M
- Amount sold
- $44.2M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
- Greg WoodDirector
- Bryan GammonDirector
- Patrick BalthropDirector
- Nicolas ArabExecutive Officer, Director
- Nicholas NaclerioDirector
- Offering amount
- $32M
- Amount sold
- $23.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6MraisedJul 2020 · 1 investors · BiotechnologyRule 506(b)
- Nicholas NaclerioDirector
- Greg WoodDirector
- Bryan GammonDirector
- Nicolas ArabExecutive Officer, Director, Promoter
- Patrick BalthropDirector
- Offering amount
- $9M
- Amount sold
- $6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.4MraisedOct 2019 · 13 investors · BiotechnologyRule 506(b)
- Nicolas ArabExecutive Officer, Director, Promoter
- Ross JohnsonExecutive Officer, Promoter
- Bryan GammonDirector
- Gregory WoodDirector
- Oscar B. Marx IIIDirector
- Patrick J. Balthrop, Sr.Director
- Offering amount
- $7M
- Amount sold
- $6.4M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.5MraisedApr 2018 · 10 investors · BiotechnologyRule 506(b)
- Johnson RossExecutive Officer
- Gregory WoodDirector
- Bryan GammonDirector
- Nicolas ArabExecutive Officer, Director
- Oscar MarxDirector
- Patrick BalthropDirector
- Offering amount
- $4M
- Amount sold
- $3.5M
- Minimum investment
- $25K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Pattern Bioscience.
In the news
Frequently asked questions
- What does Pattern Bioscience do?
- Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
- Who founded Pattern Bioscience?
- Pattern Bioscience was founded by Nick Arab, Ross Johnson in 2016.
- Who are Pattern Bioscience's investors?
- Pattern Bioscience's investors include AMR Action Fund, Illumina Ventures, Illumina Innovation.
- How much funding has Pattern Bioscience raised?
- Pattern Bioscience has disclosed $83.7M raised across 5 of its 6 known rounds.
- Where is Pattern Bioscience headquartered?
- Pattern Bioscience is headquartered in Austin, US.